Evidence map›Paper›PMID 32903120›Full record

ArticleJCO global oncology2020

Feasibility Study of a Smartphone Application for Detecting Skin Cancers in People With Albinism.

Fidel Rubagumya, Sarah K Nyagabona, Ahuka N Longombe, Achille Manirakiza, John Ngowi, Theoneste Maniragaba, Doriane Sabushimike, Sandra Urusaro, Diane A Ndoli, Nazima Dharsee and 4 more

Open access · goldAbstract read
In one paragraph

Article in JCO global oncology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 15 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 7 institutions in 4 countries.

Fidel RubagumyaDepartment of Oncology, Rwanda Military Hospital, Kigali, Rwanda.
Sarah K NyagabonaDepartment of Epidemiolgy, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania.
Ahuka N LongombePolyclinique du Millénaire de Kisangani, Kisangani, Democratic Republic of Congo.
Achille ManirakizaDepartment of Oncology, Rwanda Military Hospital, Kigali, Rwanda.
John NgowiDepartment of Oncology, Ocean Road Cancer Institute, Dar es Salaam, Tanzania.
Theoneste ManiragabaDepartment of Oncology, Rwanda Military Hospital, Kigali, Rwanda.
Doriane SabushimikeDepartment of Dermatology, Regional Dermatology Training Center, Moshi, Tanzania.
Sandra UrusaroInshuti Mubuzima, Kigali, Rwanda.
Diane A NdoliDepartment of Oncology, Ocean Road Cancer Institute, Dar es Salaam, Tanzania.
Nazima DharseeDepartment of Oncology, Ocean Road Cancer Institute, Dar es Salaam, Tanzania.
Julius MwaiselageDepartment of Oncology, Ocean Road Cancer Institute, Dar es Salaam, Tanzania.
Daudi MavuraDepartment of Dermatology, Regional Dermatology Training Center, Moshi, Tanzania.
Timothy P HannaDivision of Cancer Care and Epidemiology, Cancer Research Institute at Queen's University, Kingston, Canada.
Nazik HammadDivision of Cancer Care and Epidemiology, Cancer Research Institute at Queen's University, Kingston, Canada.
Muhimbili University of Health and Allied Sciences · TZKilimanjaro Christian Medical Centre · TZOcean Road Cancer Institute · TZQueen's University · CARwanda Military Hospital · RWUniversité de Kisangani · CDUniversity of Global Health Equity · RW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeAlbinism affects some facets of the eye's function and coloration, as well as hair and skin color. The prevalence of albinism is estimated to be one in 2,000-5,000 people in sub-Saharan Africa and one in 270 in Tanzania. People in Tanzania with albinism experience sociocultural and economic disparities. Because of stigma related to albinism, they present to hospitals with advanced disease, including skin cancers. Mobile health (mHealth) can help to bridge some of the gaps in detection and treatment of skin cancers affecting this population.

methodsWe assessed the feasibility of using a mobile application (app) for detection of skin cancers among people with albinism. The study was approved by the Ocean Road Cancer Institute institutional review board. Data, including pictures of the lesions, were collected using a mobile smartphone and submitted to expert reviewers. Expert reviewers' diagnosis options were benign, malignant, or unevaluable.

resultsA total of 77 lesions from different body locations of 69 participants were captured by the NgoziYangu mobile app. Sixty-two lesions (81%) were considered malignant via the app and referred for biopsy and histologic diagnosis. Of those referred, 55 lesions (89%) were biopsied, and 47 lesions (85%) were confirmed as skin malignancies, whereas eight (15%) were benign.

conclusionWith an increasing Internet coverage in Africa, there is potential for smartphone apps to improve health care delivery channels. It is important that mobile apps like NgoziYangu be explored to reduce diagnostic delay and improve the accuracy of detection of skin cancer, especially in stigmatized groups.

Indexed as

AlbinismSkin NeoplasmsDelayed DiagnosisFeasibility StudiesHumansSmartphoneTanzania

Identifiers

PMID32903120
PMCPMC7531610
OpenAlexW3084079428

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.